A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
Registry of Trialsclinicaltrials.gov
Year 2007

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
The purpose of this study is to demonstrate the efficacy and safety of adalimumab for the induction of clinical remission in Japanese subjects with Crohn\'s disease.
Epistemonikos ID: 715b4e874043634c0cffdd309452b00b944235b6
First added on: Jul 30, 2018